Keisuke Kiba

Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort

Makito Miyake, Nobutaka Nishimura, Yuki Oda et al. · Japanese Journal of Clinical Oncology · 2023 · 37 citations

Medicine, Oncology, Pharmacology +17

Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study

Makito Miyake, Takuto Shimizu, Yuki Oda et al. · Japanese Journal of Clinical Oncology · 2022 · 20 citations

Medicine, Oncology, Pharmacology +14

Linkage of Lower Urinary Tract Symptoms to Sleep Quality in Elderly Men with Nocturia: A Community Based Study Using Home Measured Electroencephalogram Data

Chie Matsushita, Kazumasa Torimoto, Daisuke Goto et al. · The Journal of Urology · 2016 · 18 citations · Full text

Medicine, Geriatric Medicine, Urology +17

Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

Takuto Shimizu, Makito Miyake, Nobutaka Nishimura et al. · Cancers · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma

Makito Miyake, Takuto Shimizu, Nobutaka Nishimura et al. · Clinical Genitourinary Cancer · 2021 · 15 citations

Medicine, Oncology, Pharmacology +11